Concepedia

Weike Bao

WB

24

Publications

3.1K

Citations

22

H-Index

1993

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Pathways Behavioral Services

GlaxoSmithKline (United Kingdom)

University of Louisville

Lung Institute

Weike Bao is an author at GlaxoSmithKline (United States) specializing in medicine, cardiovascular disease, and physiology.

Top concepts

Publications per year

1993–2017

24

Publications

24

The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene

Yiru Guo, W. Keith Jones, Yu-Ting Xuan et al. · Proceedings of the National Academy of Sciences · 1999 · 384 citations

An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure

Kevin S. Thorneloe, Mui Cheung, Weike Bao et al. · Science Translational Medicine · 2012 · 328 citations

In Vivo Myocardial Protection From Ischemia/Reperfusion Injury by the Peroxisome Proliferator–Activated Receptor-γ Agonist Rosiglitazone

Tianli Yue, Jun Chen, Weike Bao et al. · Circulation · 2001 · 295 citations · Full text

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

Robert N. Willette, Weike Bao, Sandhya S. Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 291 citations

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

David G. Johns, David J. Behm, Deborah J. Walker et al. · British Journal of Pharmacology · 2007 · 241 citations · Full text

Rows per page

1–5 of 24